Auxano Advisors, LLC Biogen Inc. Transaction History

Auxano Advisors, LLC

$348 Million
Q2 2024

A detailed history of Auxano Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Auxano Advisors, LLC holds 2,578 shares of BIIB stock, worth $520,240. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,578

Previous 2,640 2.35%

Holding current value

$520,240

Previous $569,000 4.92%

% of portfolio

0.17%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$190.52 - $236.72 $11,812 - $14,676	-62 Reduced 2.35%	2,578 $597,000
Q1 2024 May 02, 2024	BUY	$212.02 - $267.71 $94,136 - $118,863	444 Added 20.22%	2,640 $569,000
Q4 2023 Feb 05, 2024	BUY	$222.59 - $267.94 $4,451 - $5,358	20 Added 0.92%	2,196 $568,000
Q3 2023 Nov 07, 2023	BUY	$253.3 - $285.89 $1,773 - $2,001	7 Added 0.32%	2,176 $559,000
Q1 2023 Apr 27, 2023	BUY	$256.56 - $292.34 $27,708 - $31,572	108 Added 5.24%	2,169 $603,000
Q4 2022 Feb 03, 2023	SELL	$252.44 - $306.72 $16,913 - $20,550	-67 Reduced 3.15%	2,061 $570,000
Q3 2022 Nov 02, 2022	BUY	$194.69 - $268.46 $140,760 - $194,096	723 Added 51.46%	2,128 $568,000
Q2 2022 Aug 05, 2022	BUY	$187.54 - $223.02 $75,766 - $90,100	404 Added 40.36%	1,405 $287,000
Q1 2022 May 06, 2022	BUY	$193.77 - $244.14 $19,377 - $24,414	100 Added 11.1%	1,001 $211,000
Q4 2021 Feb 04, 2022	BUY	$223.92 - $287.77 $5,150 - $6,618	23 Added 2.62%	901 $216,000
Q2 2021 Aug 06, 2021	BUY	$259.0 - $414.71 $5,698 - $9,123	22 Added 2.57%	878 $304,000
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $207,965 - $243,643	856 New	856 $239,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxano Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Auxano Advisors, LLC with notifications on news.

Account

Auxano Advisors, LLC Biogen Inc. Transaction History